Ever wondered why you wake up feeling like a rag doll that can’t move her bones to even give a thumbs up to whichever inconsiderate thing that committed the heinous crime of killing your dreams? Well, I with no regret can tell you that chivalry is still alive as some scientists at the Manchester University have discovered the answer to one of the biggest suffering and according to them we wake up stiff in the morning because our body still hasn’t produced the natural anti-inflammatory proteins which make muscles movement an easy task.
When we wake up in the morning we feel stiff and sore because similar to our mind the body is also recuperating and it hasn’t had enough time to release the natural ibuprofen, also called the ‘cryptochrome protein’ by countering the pro-inflammatory hormones. Our biological clock suppresses all the anti-inflammatory proteins when we go to sleep at night. So by the time we have stretched and washed our face the supply of ibuprofen starts pumping through our blood, making the aches of the morning a fleeting state.
Not only is this finding an answer to a phenomenon we all have wondered from time to time but it can help scientists come up with better treatment methods for people with acute inflammation.
“By understanding how the biological clock regulates inflammation, we can begin to develop new treatments, which might exploit this knowledge,” Dr Julie Gibbs.
For instance, if we know the exact time when inflammatory proteins of our body are at work then we can make anti-inflammatory therapies more effective. It will be akin to knowing the battle plans of the enemy troops, which can be the key to victory in the battle against chronic inflammatory illnesses. The treatment method of especially perilous disease like rheumatoid arthritis can be completely remodeled. This discovery may be a landmark because arthritis infests the bones in our body in such a way that retards them. Similarly, figuring out the mechanism of inflammatory processes can pave the way for innovative drugs with special targets.